drugset / Trial / NCT04422899
Effect of Intravitreally Administered AIV007 in Subjects With Neovascular Age-Related Macular Degeneration
Non-randomizedSequentialOpen-labelTreatment
Summary
To determine safety, pharmacokinetics, and duration of effect of intravitreally administered AIV007 gel suspension in subjects with neovascular age-related macular degeneration
Timeline
- Start
- 2020-08-28
- Primary completion
- 2021-09-29
- Completion
- 2022-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AIV007 | Unknown | — | Intravitreal |
| Subject | Lenvatinib | Small molecule | — | Intravitreal |